Using unsupervised hierarchical clustering of the differentially expressed autoantigens by SAM, we determined that systemic sclerosis and morphea autoantibody reactivities exhibited distinct biosignatures that were largely associated with the presence of anti-MBP in morphea, but not in SSc or healthy controls. This evidence concerns the gene MBP and systemic sclerosis.